Cardiac troponin I in breast cancer patients receiving anthracycline chemotherapy

被引：0
|
作者：
Bauer-Kosinska, B
Miskiewicz, ZC
Kaminska, J
Kowalska, M
Pienkowski, T
机构：
[1] Maria Sklodowska Curie Mem Canc Ctr, Breast Canc Dept, Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiol, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80443-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [41] Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy
    van Dalen, E. C.
    van der Pal, H. J. H.
    Caron, H. N.
    Kremer, L. C. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [42] Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy
    van Dalen, Elvira C.
    van der Pal, Helena J. H.
    Caron, Huib N.
    Kremer, Leontien C. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [43] CARDIAC AND SKELETAL MUSCLE ENERGETIC PATHWAYS FOLLOWING ANTHRACYCLINE CHEMOTHERAPY FOR BREAST CANCER
    Gamble, David
    Khan, Hilal
    Ross, James
    Cheyne, Lesley
    Rudd, Amelia
    Horgan, Graham
    Hannah, Andrew
    Urquhart, Gordon
    Masannat, Yazan
    Elsberger, Beatrix
    Sharma, Ravi
    Dawson, Dana K.
    HEART, 2022, 108 : A109 - A109
  • [44] Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
    Hatse, Sigrid
    Serena, Marta
    Vulsteke, Christof
    Punie, Kevin
    Neven, Patrick
    Smeets, Ann
    Laenen, Annouschka
    Wildiers, Hans
    TRANSLATIONAL ONCOLOGY, 2022, 26
  • [45] Increased levels of cardiac troponin I in cancer patients
    Missov, E
    Calzolari, C
    Pau, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 15130 - 15130
  • [46] Antiemetic efficacy of intravenous (IV) NEPA in patients with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy.
    Schwartzberg, Lee S.
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [47] Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy
    Alexandre Chan
    Christy Chen
    Joen Chiang
    Sze Huey Tan
    Raymond Ng
    Supportive Care in Cancer, 2012, 20 : 1525 - 1532
  • [48] Once weekly epoetin beta in patients with metastatic breast cancer receiving anthracycline- or taxane-based chemotherapy
    Leonard, Robert C.
    Aapro, Matti
    Chen, Stephen
    Dirix, Luc Y.
    Mayordomo, Jose
    Reichert, Dietmar
    Untch, Michael
    ANNALS OF ONCOLOGY, 2004, 15 : 50 - 50
  • [49] Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy A Randomized Clinical Trial
    Livi, Lorenzo
    Barletta, Giuseppe
    Martella, Francesca
    Saieva, Calogero
    Desideri, Isacco
    Bacci, Carlotta
    Del Bene, Maria Riccarda
    Airoldi, Mario
    Amoroso, Domenico
    Coltelli, Luigi
    Scotti, Vieri
    Becherini, Carlotta
    Visani, Luca
    Salvestrini, Viola
    Mariotti, Matteo
    Pedani, Fulvia
    Bernini, Marco
    Sanchez, Luis
    Orzalesi, Lorenzo
    Nori, Jacopo
    Bianchi, Simonetta
    Olivotto, Iacopo
    Meattini, Icro
    JAMA ONCOLOGY, 2021, 7 (10) : 1544 - 1549
  • [50] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy: methodological issues
    Naderi, Mehdi
    Sabour, Siamak
    JOURNAL OF ECHOCARDIOGRAPHY, 2019, 17 (02) : 112 - 113
12345